TED FONTENOT: Open Payments
NPI 1598052052 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 37 payments from 9 companies in 2025. Trend: 2023 $1,028 · 2024 $687 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $146 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $140 |
| E.R. Squibb & Sons, L.L.C. | 7 | $110 |
| Kestra Medical Technology Services, Inc. | 2 | $79 |
| PFIZER INC. | 4 | $74 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| GENZYME CORPORATION | 1 | $33 |
| Abbott Laboratories | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LEQVIO, LifeVest, ELIQUIS, Assure WCD, VERQUVO, CAMZYOS, FABRAZYME, PERCLOSE PROSTYLE.
Industry payments across LA — which companies pay providers there.
